Ziopharm Oncology
ZIOP
#8592
Rank
ยฃ0.13 B
Marketcap
ยฃ0.64
Share price
-0.88%
Change (1 day)
-76.68%
Change (1 year)

Revenue for Ziopharm Oncology (ZIOP)

Revenue in 2021 (TTM): ยฃ2.77 Million

According to Ziopharm Oncology's latest financial reports the company's current revenue is ยฃ2.76 Million. In 2017 the company made a revenue of ยฃ4.72 Million a decrease over the revenue in the year 2016 that were of ยฃ5.07 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ziopharm Oncology from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ2.77 M
2017ยฃ4.72 M-6.88%
2016ยฃ5.07 M58.38%
2015ยฃ3.2 M215.51%
2014ยฃ1.01 M71.63%
2013ยฃ0.59 M0%
2012ยฃ0.59 M19.94%
2011ยฃ0.49 M
2001ยฃ0 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
ยฃ26.62 B 961,948.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ35.55 B 1,284,575.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
ยฃ0.46 M-83.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
ยฃ8.15 B 294,711.45%๐Ÿ‡บ๐Ÿ‡ธ USA